CEFAMANDOLE NAFATE FREE BASE

SynDRA canonical compound SYN0023474 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	respiratory tract infections \| skin infections \| urinary tract infections
Disease area	infectious disease

All known targets

cefamandole nafate
cefamandole formate sodium
cephamandole nafate
kefadol
kefandol
lampomandol
neocefal
O-Formylcefamandole
Cefamandole formate
NCGC00183035-01
Cefamandole Nafate
EINECS 260-657-6
3L768V9MWV
SCHEMBL6440440
CHEBI:53654
RRJHESVQVSRQEX-SUYBPPKGSA-N
EBC-27224
EN300-20236636
BRD-K17903788-236-01-9
O-formylcefamandole
(6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Mandokef
D00909
CEFAMANDOLE NAFATE [USP-RS]
Cefamandol nafato
Cedol
AC-1642
Cefamandole formate sodium salt
FC19846
Cemandil Sodium
Neocefal
Cefamandole nafate [USAN]
HY-B1166
Cefamandole nafate
NSC 299588
UNII-8HDO7941DO
Cefamandole Nafate sodium
GS-3575
Cefamandolnafat